News

Clarivate Unveils Innovative Features in EndNote 2025

Clarivate Unveils Innovative Features in EndNote 2025

Leading the Way in Research Solutions

Clarivate Plc (NYSE: CLVT), renowned for its innovative approach, has recently launched EndNote 2025. This upgrade introduces AI-driven tools aimed at enhancing research efficiency, ensuring scholars and researchers can focus on what matters most: advancing knowledge.

Key Features of EndNote 2025

With EndNote 2025, Clarivate aims to empower users with a suite of modern features that simplify the arduous research process. These enhancements serve to save time, improve organization, and facilitate collaboration among researchers. The key improvements include:

Generative AI-Powered Insights

The new Key Takeaway feature utilizes generative AI to extract crucial insights from research papers. This tool helps researchers quickly grasp the essential takeaways, enhancing the speed of discovery in academic pursuits.

Streamlined Journal Matching

Another standout addition is the enhanced Find a Journal tool. This machine-learning feature integrated within the Cite While You Write tool aids researchers in identifying the most suitable journals for their work, aligning their submission strategies with target publications.

Citation Management Simplified

Citing sources can often be a tedious task, but the Cite from PDF feature allows users to effortlessly insert a highlighted quote along with its citation into their documents with just a click, significantly reducing time spent on formatting.

An Enhanced User Interface

EndNote 2025 also boasts a modernized summary panel redesign, providing users with a clear and organized view of their research records. This improvement includes configurable detail options, allowing customization according to individual user needs.

Comprehensive Reference Library

The application is further strengthened by new options for viewing articles from Web of Science that cite existing records. This makes it easier for researchers to curate a more extensive and relevant reference library.

Additionally, improvements to the Find Reference Updates and Find Full-Text functionalities have been made, allowing easier access to these tools from the record menu, thereby enhancing the overall user experience.

Future Enhancements on the Horizon

Looking ahead, EndNote has plans to unveil further AI features, including the EndNote Research Assistant, scheduled for release in late 2025. This new functionality is anticipated to further enrich the user experience, making the research process even more seamless.

Foundation in AI Technology

At the core of these advancements is Clarivate's Academic AI Platform, a robust framework that ensures consistent and accelerated deployment of AI features across all its solutions. This underlying technology allows Clarivate to continually innovate and bring cutting-edge tools to researchers.

About Clarivate

Clarivate is recognized as a leading global provider of transformative intelligence. It specializes in delivering enriched data, insights, and analytics alongside expert services across various sectors, including Academia, Intellectual Property, and Life Sciences. For further information, you can visit www.clarivate.com.

Frequently Asked Questions

What is EndNote 2025?

EndNote 2025 is the latest version of Clarivate's reference management tool, which introduces new features to enhance the research process.

What AI capabilities are included in EndNote 2025?

EndNote 2025 includes generative AI tools that help extract key insights, facilitate journal matching, and simplify citation management.

How does EndNote 2025 help researchers?

The new features in EndNote 2025 automate tedious tasks, allowing researchers to save time and enhance their overall productivity with their scholarly work.

When will additional features be available?

Clarivate plans to release more AI features, including the EndNote Research Assistant, later in 2025.

How can I learn more about Clarivate?

For more details about Clarivate's offerings and services, please visit their official website at www.clarivate.com.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Morpho Unveils Versatile UV Printer at IFA 2026

Updated Category News Views 1

IFA 2026: A New Frontier for Desktop Printing You've seen your fair share of printers over the years, but when a company like Morpho steps onto the scene with a gadget that echoes innovation, it makes you perk up those market-ears. We're talking the big unveil of their desktop UV printer at the IFA 2026 in Berlin. Morpho's contraption isn't just spewing out ink; it's...

Continue Reading
Dreame's High-Tech Kitchen Innovations Unveiled at IFA 2026

Updated Category News Views 3

The Gadgets Turning Heads at IFA 2026 Cooking's gone high-tech, and it's about time. At the IFA 2026 in Berlin, Dreame Technology rolled out some primo small kitchen appliances that might just leave the old-school gear collecting dust. We're talking slick machines across six major categories: air fryers, coffee gizmos, mixers, blenders, toasters, and treat makers. Forget...

Continue Reading
LiberNovo Spotlights Ergonomic Seating at Berlin's IFA 2026

Updated Category News Views 0

LiberNovo Sets the Stage at IFA 2026 If you're poking around Berlin this September, the Messe Berlin is the place to be, especially for those keeping tabs on the consumer tech world. LiberNovo, the ergonomic seating company you might not have had on your radar, is out here making noise. They're throwing down the gauntlet with the Maxis Series, promising a better deal for...

Continue Reading
Sarepta Under Scrutiny: KSF's Investigation Deepens

Updated Category News Views 5

A Troubling Chapter for Sarepta Therapeutics It's not every day that a company's dirty laundry gets hung out for all to see, especially when we're talking about Sarepta Therapeutics, a player in the rare disease treatment space. But that's exactly where we find ourselves this fine day—a bit like kicking a hornet's nest, if you ask me. Led by the former Louisiana...

Continue Reading
TCL Drives Fan Experience at FIBA Women's World Cup

Updated Category News Views 5

TCL's Slam Dunk on the Global Stage The FIBA Women's Basketball World Cup 2026 in Berlin is set to showcase some incredible talent, and TCL is right in the thick of it. As a FIBA Global Partner, they're spearheading a new wave of fan interactions with their TCLforHer initiative, focusing on tech-enabled fan experiences that go beyond just watching the game. This isn't...

Continue Reading
Carles Puyol Joins Midea at IFA 2026, Celebrating Unity

Updated Category News Views 3

Leadership, Innovation, and Soccer Collide in Berlin When you’ve got a Barcelona legend like Carles Puyol gracing an event, it's more than just fanfare. This time around, Puyol made waves at Midea's stand during IFA 2026 in Berlin, signaling a strategic power move for both Midea and FC Barcelona. We're talking about a scene where tech innovation meets world-class...

Continue Reading
Signant and Lothar Forge Future in Clinical Trials

Updated Category News Views 1

Breathing New Life into Clinical Trials Alright, folks, listen up. We've got a fresh collaboration cooking that could shake things up in the clinical trial sector. Signant Health, a heavyweight in clinical trial solutions, has teamed up with Lothar Medical, and they’ve hitched their wagons to launch something rather intriguing: the ALDS PRO pulmonary function tech. Let...

Continue Reading
LG's High-Purity RGB Displays Shine at IFA 2026

Updated Category News Views 2

LG's Latest Dazzler: RGB Evo Takes the Spotlight LG has never been shy about setting standards in the home entertainment sector, and they’re doing it again at IFA 2026 with their high-purity RGB displays. Make no mistake, when LG rolls out a massive LCD TV certified by TÜV Rheinland for color purity, every other home theater manufacturer is scrambling to keep up. "LG...

Continue Reading
CHiQ Secures AI Award, Elevates Smart Home Living

Updated Category News Views 2

CHiQ's Big Win in the AI Game In a world where technology rarely stops spinning, CHiQ has carved its own commendable niche. Snagging the AI Home Ecosystem Brand Award at IFA 2026 in Berlin, the brand's knack for pioneering AI tech isn't just a footnote—it's the whole story. The award—enough to make your competitors green with envy—highlights how far they've come in...

Continue Reading
Hims & Hers Faces Legal Storm Over Alleged Privacy Breaches

Updated Category News Views 1

Legal Storms Brew Over Alleged Privacy Breaches Well, here we go again, folks. Just when you think the waters are calming, Hims & Hers Health, Inc. (NYSE: HIMS) finds itself in the thick of a nasty securities fraud class action lawsuit. Allegedly they've been less than honest with their customers' health info—something about sneaking around with people's sensitive data...

Continue Reading

Top 5 Most Recently Viewed Articles

Barry Jay 'BJ' Dekreek Makes Strategic Move to Avantax for Client Growth

Updated Category News Views 178

Barry Jay 'BJ' Dekreek Joins Avantax for Enhanced Services Barry Jay "BJ" Dekreek, a former professional golfer, has made the strategic decision to move his advisory practice from LPL to Avantax. This transition aims to better serve high-net-worth clients and leverage partnerships with CPAs. Dekreek is now affiliated with Legacy Capital Advisors, LLC, which is part of the...

Continue Reading
Projected Growth in the Brushless DC Motor Sector by 2030

Updated Category News Views 136

Significant Growth in the Brushless DC Motor Market The global Brushless DC Motor market is set to undergo dramatic growth, with current estimates predicting a surge from USD 14.02 billion to USD 20.68 billion by 2030. This remarkable growth, reflecting a compounded annual growth rate (CAGR) of 8.1%, is driven by the increasing demand for energy-efficient and...

Continue Reading
Impacts of Tariff Uncertainty on Investments and Markets

Updated Category News Views 144

Understanding the Effects of Tariff Policies on Investments Financial markets are always in flux, but recent wave patterns indicate something significant is occurring concerning tariff policies. Unusual market behaviors have surfaced, particularly following judicial inquiries into the administration's tariff authority. Interestingly, this situation has led to an...

Continue Reading
Insights into Upcoming Earnings for PNC Financial Services

Updated Category News Views 174

What Investors Can Anticipate from PNC Financial Services Group As PNC Finl Servs Gr (NYSE: PNC) gears up for the announcement of its quarterly earnings, investors are keen to understand what this could mean for their investments. The company is set to release its earnings soon, and there are a few critical points to keep in mind. Projected Earnings Overview Leading...

Continue Reading
PolyPid's Phase 3 Trial Success: Impactful Findings from SHIELD II

Updated Category News Views 257

PolyPid's Phase 3 SHIELD II Trial Yields Encouraging Outcomes PolyPid Ltd. (NASDAQ: PYPD), a pioneering biopharmaceutical company, has recently announced promising results from its Phase 3 SHIELD II trial. This pivotal study evaluates D-PLEX100, aimed at preventing surgical site infections (SSIs) in patients undergoing large abdominal surgical interventions. The results...

Continue Reading